SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
₹1,758.80
arrow_downward
-0.29%(-5.20) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa SUNPHARMA...
Buksan
₹1,762.20
Mataas
₹1,764.90
Mababa
₹1,743.50
Mkt. cap
4.22T
Avg. na dami
1.45M
Dami
1.52M
Dividend
0.91%
Bawat tatlong buwang dividend
₹4.00
Petsa ng ex-dividend
Hul 7, 2026
P/E ratio
34.87
Mataas nang 52-wk
₹2,046.90
Mababa nang 52-wk
₹1,583.70
EPS
₹50.44
Mga natitirang share
0.00
Bilang ng mga empleyado
47K
Buksan
₹1,762.20
Mataas
₹1,764.90
Mababa
₹1,743.50
Mkt. cap
4.22T
Avg. na dami
1.45M
Dami
1.52M
Dividend
0.91%
Bawat tatlong buwang dividend
₹4.00
Petsa ng ex-dividend
Hul 7, 2026
P/E ratio
34.87
Mataas nang 52-wk
₹2,046.90
Mababa nang 52-wk
₹1,583.70
EPS
₹50.44
Mga natitirang share
0.00
Bilang ng mga empleyado
47K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
1 araw ang nakalipas
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
·
2 araw ang nakalipas
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Tungkol sa Sun Pharmaceutical Industries Ltd